49 Wealth Management’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$260K Buy
+13,673
New +$246K 0.02% 192
2026
Q2
– Sell
-11,906
Closed -$119K – 307
2026
Q1
$119K Buy
+11,906
New +$176K 0.01% 194

Other funds holding BBNX

49 Wealth Management's BBNX Position: Q3 2026 in Review

49 Wealth Management opened a new position in Beta Bionics (BBNX) in Q3 2026: 13,673 shares worth $260K. The stake represents 0.02% of the portfolio and ranks #192 among its holdings. This is a return to the name: 49 Wealth Management previously reported a position in BBNX as recently as Q1 2026.

49 Wealth Management first reported a position in BBNX in Q1 2026 and has held it in 2 quarters since. 153 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • 49 Wealth Management held 13,673 shares of Beta Bionics worth $260K as of Q3 2026.
  • Beta Bionics was a new 49 Wealth Management position in Q3 2026.
  • Beta Bionics made up 0.02% of 49 Wealth Management's portfolio in Q3 2026, its #192 holding.
  • 49 Wealth Management first reported a position in Beta Bionics in Q1 2026 and has held it in 2 quarters since.
  • 153 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on 49 Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.